Special Announcement - Now Enrolling for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for the first of its kind FDA approved stem cell clinical trial for knee arthritis. Our clinic is now enrolling patients in this trial. Contact us at 312-475-1893 for details. Click here to learn more.

Dr. Sheinkop, Mt Prospect & Chicago, IL, Autologous Platelet Concentrate Fluid

Announcing the addition of a new cell-concentration approach to arthritis

best des plaines orthopedic surgeonAs many are aware, I was an invited speaker to the Russian Orthopedic Society this past November. Although the purpose was for me to educate the attendees about advances in Cellular Orthopedics and Regenerative Medicine, I did become aware that a particular approach to arthritis under investigation in Europe in which I had great personal interest might soon be available for me in the United States. Three weeks ago, I underwent an autologous cellular and platelet concentration intervention into both of my knees so I could stay active and continue to pursue my personal fitness and recreational interests.

The Autologous Platelet Concentrate Fluid is designed to introduce anti-inflammatory cytokines and anabolic growth factors so as to decrease pain and promote cartilage well-being. Owing to my age, my circulating blood was used in a single injection in an attempt to stimulate my cartilage cell proliferation, block further cartilage destruction and slow my cartilage degradation. In a younger patient, I would chose Bone Marrow Concentrate as the means for blocking the inflammatory proteins Interleukin-1(IL-1) and Tissue Necrosis Factor-alpha (TNF-a). We now are able to offer this single injection intervention to those who might otherwise chose a Total Joint Replacement or who have not responded to previous regenerative interventions

Pin It on Pinterest

Share This